These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15901832)

  • 1. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells.
    Im E; Venkatakrishnan A; Kazlauskas A
    Mol Biol Cell; 2005 Aug; 16(8):3488-500. PubMed ID: 15901832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma.
    Malla RR; Gopinath S; Gondi CS; Alapati K; Dinh DH; Gujrati M; Rao JS
    Cancer Gene Ther; 2011 Jun; 18(6):419-34. PubMed ID: 21394106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation.
    Cavallo-Medved D; Rudy D; Blum G; Bogyo M; Caglic D; Sloane BF
    Exp Cell Res; 2009 Apr; 315(7):1234-46. PubMed ID: 19331819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.
    Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G
    J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
    Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
    Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-selectin is required for the antiangiogenic activity of endostatin.
    Yu Y; Moulton KS; Khan MK; Vineberg S; Boye E; Davis VM; O'Donnell PE; Bischoff J; Milstone DS
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8005-10. PubMed ID: 15148373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro.
    Premzl A; Turk V; Kos J
    J Cell Biochem; 2006 Apr; 97(6):1230-40. PubMed ID: 16315320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging impairs transcriptional regulation of vascular endothelial growth factor in human microvascular endothelial cells: implications for angiogenesis and cell survival.
    Ahluwalia A; Jones MK; Szabo S; Tarnawski AS
    J Physiol Pharmacol; 2014 Apr; 65(2):209-15. PubMed ID: 24781730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
    Xu H; Czerwinski P; Hortmann M; Sohn HY; Förstermann U; Li H
    Cardiovasc Res; 2008 May; 78(2):349-55. PubMed ID: 18056764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
    Fan W; Crawford R; Xiao Y
    Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.
    Wang B; Sun J; Kitamoto S; Yang M; Grubb A; Chapman HA; Kalluri R; Shi GP
    J Biol Chem; 2006 Mar; 281(9):6020-9. PubMed ID: 16365041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
    Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J
    J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity.
    Mirković B; Markelc B; Butinar M; Mitrović A; Sosič I; Gobec S; Vasiljeva O; Turk B; Čemažar M; Serša G; Kos J
    Oncotarget; 2015 Aug; 6(22):19027-42. PubMed ID: 25848918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.